Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia

被引:106
作者
Heo, HJ
Kim, MJ
Lee, JM
Choi, SJ
Cho, HY
Hong, BS
Kim, HK
Kim, E
Shin, DH
机构
[1] Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea
[2] Cornell Univ, Dept Food Sci & Technol, Geneva, NY 14456 USA
[3] Hanseo Univ, Dept Food & Biotechnol, Seosan, South Korea
[4] Inha Univ, Dept Biol Engn, Inchon, South Korea
关键词
naringenin; Alzheimer's disease; acetylcholinesterase; anti-amnesic agent; Citrus junos;
D O I
10.1159/000076349
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 [法学]; 0303 [社会学]; 100203 [老年医学];
摘要
This study was performed to identify safe and more effective acetylcholinesterase (AChE) inhibitors in the treatment of Alzheimer's disease. The total methanol extract of Citrus junos had a significant inhibitory effect on AChE in vitro. By sequential fractionation of C. junos, the active component was finally identified as naringenin. Naringenin inhibited AChE activity in a dose-dependent manner. In this study, we also evaluated the antiamnesic activity of naringenin, a major flavanone constituent isolated from C. junos, in vivo using ICR mice with amnesia induced by scopolamine ( 1 mg/kg body weight). Naringenin, when administered to mice at 4.5 mg/kg body weight, significantly ameliorated scopolamine-induced amnesia as measured in both the passive avoidance and the Y-maze test. These results suggest that naringenin may be a useful chemopreventive agent against Alzheimer's disease. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:151 / 157
页数:7
相关论文
共 25 条
[1]
[Anonymous], 2000, Cholinesterases and cholinesterase inhibitors
[2]
Effect of rivastigmine on scopolamine-induced memory impairment in rats [J].
Bejar, C ;
Wang, RH ;
Weinstock, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 383 (03) :231-240
[3]
Benzi G, 1988, EUR J PHARMACOL, V346, P1
[4]
An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: Comparison with other cholinesterase inhibitors [J].
Braida, D ;
Paladini, E ;
Griffini, P ;
Lamperti, M ;
Maggi, A ;
Sala, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 302 (1-3) :13-20
[5]
SERUM-PROTEINS BYPASS THE BLOOD-BRAIN FLUID BARRIERS FOR EXTRACELLULAR ENTRY TO THE CENTRAL-NERVOUS-SYSTEM [J].
BROADWELL, RD ;
SOFRONIEW, MV .
EXPERIMENTAL NEUROLOGY, 1993, 120 (02) :245-263
[6]
PATHOLOGICAL-CHANGES IN THE NUCLEUS OF MEYNERT IN ALZHEIMERS AND PARKINSONS DISEASES [J].
CANDY, JM ;
PERRY, RH ;
PERRY, EK ;
IRVING, D ;
BLESSED, G ;
FAIRBAIRN, AF ;
TOMLINSON, BE .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 59 (02) :277-289
[7]
CHOLINERGIC FUNCTION AND INTELLECTUAL DECLINE IN ALZHEIMERS-DISEASE [J].
COLLERTON, D .
NEUROSCIENCE, 1986, 19 (01) :1-28
[8]
THE BEHAVIORAL-EFFECTS OF HEPTYL PHYSOSTIGMINE, A NEW CHOLINESTERASE INHIBITOR, IN TESTS OF LONG-TERM AND WORKING MEMORY IN RODENTS [J].
DAWSON, GR ;
BENTLEY, G ;
DRAPER, F ;
RYCROFT, W ;
IVERSEN, SD ;
PAGELLA, PG .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 39 (04) :865-871
[9]
SYNAPSE LOSS IN FRONTAL-CORTEX BIOPSIES IN ALZHEIMERS-DISEASE - CORRELATION WITH COGNITIVE SEVERITY [J].
DEKOSKY, ST ;
SCHEFF, SW .
ANNALS OF NEUROLOGY, 1990, 27 (05) :457-464
[10]
A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY [J].
ELLMAN, GL ;
COURTNEY, KD ;
ANDRES, V ;
FEATHERSTONE, RM .
BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) :88-&